The Powerscourt Healthcare Fix podcast Etain Lavelle and Sarah MacLeod

As a serial entrepreneur in European life sciences companies, Edwin Moses knows a thing or two about what it takes to succeed in the industry. From leading an Oxford University spinout to being at the helm of Belgium’s first hostile takeover target, he's faced his fair share of setbacks. He now enjoys a plural career working only where he can make a difference, with companies that are "led by smart people set on changing the world."In the final Powerscourt Healthcare Fix of 2023, Edwin ...

The launch of a new mid-market fund and diverging risk appetites on either side of the Atlantic are just some of the topics touched upon by Geraldine O’Keeffe, partner at EQT Life Sciences, in the latest episode of the Powerscourt Healthcare Fix podcast. She tells host Etain Lavelle that the deployment of even tiny amounts of pension fund capital into more innovative companies would have a huge impact on the sector in Europe. While venture investing in the region has evolved successfully...

After becoming CEO of GE Healthcare in 2011, Kieran Murphy ushered the $19 billion medical technology business into new areas including gene and cell therapy and bioengineering, building on its expertise as an X-ray developer. The company later rose to the unprecedented challenges of the Covid-19 pandemic. But what lessons can be learned for the future? In this episode, Kieran talks to host Etain Lavelle about the AI-driven revolution in imaging and cancer diagnostics, the opportunities for t...

Rishi Sunak wants to make Britain a science superpower. But a lack of available scale up funding and the slow uptake of innovative new medicines are among the constraints putting his ambitions at risk. In this episode, Redx Pharma CEO Lisa Anson talks to host Etain Lavelle about the steps required to make the UK life sciences sector globally competitive, what drew her from natural sciences to industry, the big pharma skills she brought to biotech, and her one career regret. Listen to all...

The Life Sciences sector is integral to the economy, yet in the current macro environment, investors are fleeing to safety avoiding an industry traditionally associated with risk. In these troubled times, that sector needs champions more than ever.Which is what leads us to the Powerscourt Healthcare Fix. In this podcast series, we share enlightening and engaging interviews with leading figures from this essential industry. We learn about the setbacks, challenges and opportunities they h...